We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $7.09B
1-Year Est. Return 20.73%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+20.73%
3 Year Est. Return
+67.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3B
AUM Growth
-$16.3M
Cap. Flow
+$147M
Cap. Flow %
4.91%
Top 10 Hldgs %
31.29%
Holding
244
New
3
Increased
120
Reduced
105
Closed
12
Avg Time Held
6.6 quarters
Top 10 Avg Time Held
2.3 quarters
Top 20 Avg Time Held
5.6 quarters

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$34.9M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$31.1M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$26.3M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.7M

Top Sells

Rank Stock Value
1
SPTL icon
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
+$23.5M
2
BSX icon
Boston Scientific
BSX
+$15.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$13.9M
4
AVGO icon
Broadcom
AVGO
+$13.5M
5
SYK icon
Stryker
SYK
+$9.76M

Sector Composition

Rank Sector Weight
1 Healthcare 37.54%
2 Technology 21.68%
3 Miscellaneous 16.38%
4 Financials 5.79%
5 Communication Services 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TLT icon
1
iShares 20+ Year Treasury Bond ETF
TLT
$43.6B
$265M 8.85%
3,039,534
+285,825
+10% +$26.3M
2023 Q3
5 quarters
IEF icon
2
iShares 7-10 Year Treasury Bond ETF
IEF
$41.1B
$119M 3.97%
1,285,965
+329,248
+34% +$31.1M
2024 Q1
3 quarters
LLY icon
3
Eli Lilly
LLY
$1.02T
$94.9M 3.16%
122,892
+36,587
+42% +$30.3M
2022 Q4
8 quarters
NVDA icon
4
NVIDIA
NVDA
$5.65T
$90.7M 3.03%
675,688
+253,463
+60% +$34.9M
2022 Q4
8 quarters
JNJ icon
5
Johnson & Johnson
JNJ
$617B
$71.2M 2.38%
492,465
+22,491
+5% +$3.49M
2022 Q4
8 quarters
UNH icon
6
UnitedHealth
UNH
$334B
$69.1M 2.31%
136,633
+9,843
+8% +$5.59M
2022 Q4
8 quarters
MSFT icon
7
Microsoft
MSFT
$3.84T
$66.6M 2.22%
157,915
+33,500
+27% +$14.3M
2022 Q4
8 quarters
MRK icon
8
Merck
MRK
$356B
$53.9M 1.8%
542,156
+42,248
+8% +$4.36M
2022 Q4
8 quarters
ABBV icon
9
AbbVie
ABBV
$464B
$53.8M 1.79%
302,788
+29,577
+11% +$5.44M
2022 Q4
8 quarters
AMGN icon
10
Amgen
AMGN
$218B
$53.6M 1.79%
205,491
+34,152
+20% +$10.1M
2022 Q4
8 quarters
AZN icon
11
AstraZeneca
AZN
$243B
$53.3M 1.78%
407,039
+42,945
+12% +$6.01M
2022 Q4
8 quarters
BMY icon
12
Bristol-Myers Squibb
BMY
$125B
$52.8M 1.76%
932,645
-249,553
-21% -$13.9M
2022 Q4
8 quarters
ELV icon
13
Elevance Health
ELV
$83.8B
$52.1M 1.74%
141,148
+37,960
+37% +$15.9M
2022 Q4
8 quarters
DHR icon
14
Danaher
DHR
$150B
$51.8M 1.73%
225,849
+23,586
+12% +$5.8M
2022 Q4
8 quarters
A icon
15
Agilent Technologies
A
$47.3B
$51.8M 1.73%
385,841
+10,921
+3% +$1.5M
2023 Q3
5 quarters
TMO icon
16
Thermo Fisher Scientific
TMO
$242B
$51.7M 1.72%
99,326
+7,786
+9% +$4.28M
2022 Q4
8 quarters
NVS icon
17
Novartis
NVS
$268B
$51.6M 1.72%
530,340
+32,077
+6% +$3.42M
2022 Q4
8 quarters
MDT icon
18
Medtronic
MDT
$110B
$51.5M 1.72%
645,045
-44,086
-6% -$3.82M
2022 Q4
8 quarters
BSX icon
19
Boston Scientific
BSX
$61.7B
$51.4M 1.72%
575,975
-174,241
-23% -$15.3M
2022 Q4
8 quarters
ZTS icon
20
Zoetis
ZTS
$28.8B
$51.4M 1.72%
315,591
+9,491
+3% +$1.7M
2022 Q4
8 quarters
SYK icon
21
Stryker
SYK
$106B
$51.4M 1.71%
142,646
-26,338
-16% -$9.76M
2022 Q4
8 quarters
ABT icon
22
Abbott
ABT
$169B
$51.3M 1.71%
453,778
-73,354
-14% -$8.48M
2022 Q4
8 quarters
REGN icon
23
Regeneron Pharmaceuticals
REGN
$75.7B
$50.8M 1.7%
71,369
+27,029
+61% +$22.7M
2022 Q4
8 quarters
ISRG icon
24
Intuitive Surgical
ISRG
$138B
$50.6M 1.69%
96,875
-6,823
-7% -$3.55M
2022 Q4
8 quarters
VGLT icon
25
Vanguard Long-Term Treasury ETF
VGLT
$9.96B
$45.9M 1.53%
829,627
-139,286
-14% -$8.07M
2023 Q3
5 quarters
1
2 3 4 5

Similar funds

CGPCS
Capital Group Private Client Services Los Angeles, California $7.09B AUM 30.53% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $7.06B AUM 27.24% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $7.06B AUM 36.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM

Harvest Portfolios Group's Q4 2024 Portfolio in Review

As of Q4 2024, Harvest Portfolios Group held 244 positions worth $3B, down 0.54% from $3.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Harvest Portfolios Group deployed $147M of net new capital in Q4 2024, opening 3 new positions and adding to 120 existing holdings. Its largest new stake was Viking Holdings: 30,131 shares worth $1.33M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 40% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Boston Scientific, an estimated $15.3M trimmed.

  • Harvest Portfolios Group's largest Q4 2024 buy was Viking Holdings: 30,131 shares worth $1.33M.
  • Harvest Portfolios Group added most to NVIDIA in Q4 2024, an estimated $34.9M increase.
  • Harvest Portfolios Group's biggest Q4 2024 reduction was Boston Scientific, cutting an estimated $15.3M.
  • Harvest Portfolios Group fully exited State Street SPDR Portfolio Long Term Treasury ETF in Q4 2024, selling an estimated $23.5M.
  • Harvest Portfolios Group's ten largest holdings make up 31% of its $3B portfolio in Q4 2024.
  • Harvest Portfolios Group opened 3 new positions and closed 12 in Q4 2024.
  • Harvest Portfolios Group's portfolio value fell 0.54% quarter-over-quarter to $3B.

Based on Harvest Portfolios Group's 13F filing for Q4 2024, filed 14 Feb 2025.